The Effect of Ultrasound-guided Pudendal Nerve Block for Postoperative Pain Management after PPH surgery

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006427

Enrollment

Unknown

Registered

2015-05-21

Start date

2015-05-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia

Interventions

Group 1:pudendal nerve block with 0.9% saline

Group 2:pudendal nerve block with ropivacaine

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adults who have PPH surgery

Exclusion criteria

Exclusion criteria: Age=40 kg/m2; weight<50kg; coagulopathy; a history of relevant drug allergy; chronic hepatic or renal insufficiency; precnancy or breastfeeding; a history of alcohol or analgesics dependence; chronic pain; with other perianal diseases.

Design outcomes

Primary

Measure	Time frame
the time for PNB;first time of pain;Median VAS pain scores while coughing and at rest;tramadol requirements;nausea and vomiting during the first 48 postoperative hours;urinary retention;pain with first defecation;satisfaction of the patients;	—

Countries

China

Contacts

Public ContactWengang Ding

dingwg999@163.com+86 13936563265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026